Community Champion of Equity and Justice: Baltimore Racial Justice Action
Baltimore Racial Justice Action (BRJA) is a Black-led, multiracial, intergenerational organization focusing on anti-racism/anti-oppression consulting and public education while working to facilitate transformative change — individually, institutionally, and ultimately societally — toward racial justice and justice related to other oppressive systems.It works to provide tools and services to organizations and individuals interested in working to dismantle the anti-Black, white supremacist power structures within most U.S. institutions that disproportionately impact the livelihoods, health, and well-being of Black and non-Black people of color and communities, and to assist connections being made to other forms of oppression.Dottye Burt-Markowitz, one of the co-founders of the group, speaks about the organization's work as it was honored with a University of Maryland, Baltimore Community Champion of Equity and Justice Award at the 2025 Rev. Dr. Martin Luther King Jr. and Black History Month Celebration on Feb. 6.Learn more about BRJA and the awards: https://elm.umaryland.edu/elm-stories/2025/Community-Champion-of-Equity-and-Justice-Award-Winner-Baltimore-Racial-Justice-Action.php
More from Youtube
- 0:56Could Weight-Loss Drugs Curb Cravings for Addictive Substances? | Breakthroughs Can’t WaitEveryone has heard of Ozempic and Wegovy for treating diabetes and weight loss. But, what's been discovered in clinical trials, is an anti-craving effect is showing promising results for those battling alcohol and drug addiction.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
- 0:55Confronting the 4th Wave of the Drug Overdose Death Crisis | Breakthroughs Can't WaitOpioid and cocaine use epidemic is entrenched within Baltimore city, and there are no FDA-approved treatment for any stimulant disorders.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
